a month ago
MIR
AnalystsYuan ZhiYuan Zhi's Stock Forecasts
AnalystsYuan Zhi
Analyst Ranking
Top 10%
#471 out of 4997 analysts
Average Return
+34.45%
Win Rate
45%14 out of 31
Risk vs Reward
Poor
Good
Yuan Zhi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Fusion Pharmaceuticals IncFUSN | +554.97% | $3.22 | $21.09 | 2023-10-02 - 2024-03-20 | Strong Buy |
Fusion Pharmaceuticals IncFUSN | +446.37% | $3.86 | $21.09 | 2023-03-29 - 2024-03-20 | Strong Buy |
Fusion Pharmaceuticals IncFUSN | +141.92% | $2.29 | $5.54 | 2022-11-30 - 2023-11-30 | Strong Buy |
Hyperfine IncHYPR | +108.33% | $0.60 | $1.25 | 2025-05-14 - 2025-08-25 | Strong Buy |
Tango Therapeutics IncTNGX | +98.82% | $3.38 | $6.72 | 2024-11-10 - 2025-08-25 | Strong Buy |
Yuan Zhi Analyst Color
Get additional color on Yuan Zhi's coverage of popular stocks
2 months ago
CATX
a year ago
CATX
2 years ago
AZTA
Yuan Zhi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mirion Technologies IncMIR | 3 | Strong Buy | $22.00 | +6.23% | Reiterates | a month ago |
Oncology Institute IncTOI | 1 | Strong Buy | $6.00 | +72.91% | Initiates Coverage On | a month ago |
Perspective Therapeutics IncCATX | 3 | Strong Buy | $12.00 | +246.82% | Maintains | 2 months ago |
Radnet IncRDNT | 1 | Strong Buy | $69.00 | -0.85% | Initiates Coverage On | 2 months ago |
Hyperfine IncHYPR | 2 | Strong Buy | $1.00 | -20.00% | Maintains | 3 months ago |
Radiopharm Theranostics LtdRADX | 1 | Strong Buy | $15.00 | +167.86% | Initiates Coverage On | 6 months ago |
Tango Therapeutics IncTNGX | 2 | Strong Buy | $8.00 | +19.05% | Maintains | 9 months ago |
Agenus IncAGEN | 2 | Strong Buy | $18.00 | N/A | Maintains | a year ago |
Cryoport IncCYRX | 4 | Strong Buy | $15.00 | N/A | Upgrades | a year ago |
Cytosorbents CorpCTSO | 1 | Strong Buy | $3.00 | N/A | Reiterates | a year ago |
Fusion Pharmaceuticals IncFUSN | 4 | Hold | $23.00 | N/A | Downgrades | a year ago |
Azenta IncAZTA | 3 | Strong Buy | $79.00 | N/A | Maintains | 2 years ago |
Ambrx Biopharma IncAMAM | 2 | Hold | $28.00 | N/A | Downgrades | 2 years ago |
Actinium Pharmaceuticals IncATNM | 4 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Iveric Bio IncISEE | 3 | Hold | $19.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.